1Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantanblecardioverter debfibrillators to reduce patient morbidity [NCT00279279]

Trials

Volumn 7, Issue , 2006, Pages

  Wilkoff, Bruce L ^a   Stern, Richard ^b   Williamson, Brian ^c   Wathen, Mark ^d   Holloman, Keith ^e   Fieberg, Ann ^e   Brown, Mark ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Doctors Medical Center   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; EXPERIMENTAL DESIGN; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PATIENT SAFETY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

EID: 33746614024     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-7-18     Document Type: Article

References (22)

1. AVID Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. NEJM 1997, 337:1576-1583.
2. Connolly S, Gent M, Roberts R, Dorian P, Roy D, Shelton R, Mitchel L, Green M, Klein G, O'Brien B, for the CIDS Investigators: Canadian Implantable Defibrillator Study (CIDS). Circulation 2000, 101:1297-1302.
3. Kuck K, Cappato R, Siebels J, Ruppel R, for the CASH investigators: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102:748-754.
4. Buxton AE, Lee KL, Fisher JD, Josephson M, Prystowsky EN, Hafley G: A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. NEJM 1999, 341:1882-1890.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia. NEJM 1999, 335:1933-1940.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgings SL, Brown M, Andrews ML: Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. NEJM 2002, 346:877-883.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. N Engl J Med 2005, 352(20):2146.
8. Centers for Medicare & Medicaid Services(CMS) Decision Memo for Coverage of Implantable Defibrillators. January 27, 2005
9. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis AB, Conti JB: Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. PACE 2000, 23:1-6.
10. Luderitz B, Jung W, Deister A, Marneros A, Manz M: Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. PACE 1999, 16(9):1815-21.
11. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, for the EMPIRIC Trial Investigators: A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators: Results from the Prosepective Randomized Multicenter EMPIRIC Trial. in press.
12. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Koroush K, Machado C, Rubenstein DS, Volosin KJ: Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients with Implantable Cardioverter-Defibrillators. Circulation 2004, 110:2591-2596.
13. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff BL, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, The MIRACLE ICD Trial Investigators: Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure. Journal of the American Medical Association 2003, 289(20):2685-2721.
14. Wilkoff BL, Hess M, Young J, Abraham WT: Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysio 2004, 15:1002-1009.
15. Ousdigian K, Gillberg J, Koehler J, Stadler R, DeGroot P, Olson W, for the Worldwide GEM DR Investigators: How Often Is ICD-Detected VF Actually Monomorphic VT? PACE 2001, 24:731.
16. Gunderson B, Olson W, Brown T, Swerdlow C, and the GEM DRClinical Worldwide Investigators: Increasing the Number of Intervals for VF Detection Increases Implantable Cardioverter-Defibrillator Longevity. Circulation 2002, 106(19):II-322.
17. DeGroot P, Sharma V, Wathen M, Sweeney M, Chisner M, Machado C, Adkisson W, Koehler J, Stark A, for the PainFREE Rx Investigators: Implantable Cardioverter Defibrillator Detected Ventricular Fibrillation with Cycle Length < 240 is Predominantly Fast Monomorphic Tachycardia. PACE 2001, 24:722.
18. Wathen M, Sweeney M, DeGroot P, Stark A, Koehler J, Chisner M, Machado D, Adkisson W: Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardias in Patients with Coronary Artery Disease. Circulation 2000, 104:769-801.
19. Schaumann A, Muhlen F, Herse B, Gonska B, Kreuzer H: Empirical Versus Tested Anti-tachycardia Pacing in Implantable Cardioverter Defibrillators. Circulation 1998, 97:66-74.
20. Russo AM, Nayak H, Verdino R, et al.: Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified? Pacing Clin Electrophysiol 2003, 26(12):2289-2295.
21. Ousdigian K, Wilkoff B, Morgan J, Sterns L, Wang Z, Wilson R: ICD Patients with a History of Spontaneous Sustained VT Have Different Outcomes Than Other Secondary or Primary Prevention Patients. Circulation 2005, 112(17):ii-374.
22. Rosner B: Fundamentals of Biostatistics. Fourth edition. Wadsworth Publishing Company; 1995.